Press Releases

STEINHAUSEN, Switzerland, June 04, 2024 (GLOBE NEWSWIRE) -- Transocean Ltd. (NYSE: RIG) (“Transocean”) today announced contract fixtures for three of its harsh environment semisubmersibles. Together, the fixtures represent approximately $161 million in firm contract backlog.

In Norway, Transocean Spitsbergen was awarded a three-well contract extension with Equinor. The program is expected to commence in the fourth quarter of 2025 in direct continuation of the... (continue reading...)

Neurai appoints Anndy Lian as Chairman of the Board to enhance its AI-driven fintech solutions, leveraging his extensive experience in blockchain and digital advisory roles.

Singapore, Singapore--(Newsfile Corp. - June 4, 2024) - Neurai, a startup AI technology company specializing in fintech solutions, has announced the appointment of Anndy Lian as the Chairman of the Board. Lian, a seasoned business strategist in Asia, brings extensive experience and expertise to his... (continue reading...)

NEW YORK--(BUSINESS WIRE)-- Consortium Brand Partners (CBP), a leading and innovative consumer-focused investment manager, has announced the acquisition of Outdoor Voices (OV), the inspiring athleisure lifestyle brand founded in 2013 by Tyler Haney. This marks CBP’s second acquisition, following its announcement of a majority stake in Reese Witherspoon’s fashion & lifestyle brand, Draper James in September 2023.

This press release features multimedia. View the... (continue reading...)

Vancouver, British Columbia--(Newsfile Corp. - June 4, 2024) - Midnight Sun Mining Corp. (TSXV: MMA) (OTC Pink: MDNGF) (the "Company" or "Midnight Sun") is pleased to announce the appointment of Margot Naudie to the Company's Advisory Board.

Al Fabbro, Midnight Sun's President & CEO, stated: "On behalf of the directors and management, I would like to welcome Margot to our team. I believe her depth of capital markets experience, specializing in natural resources, will be... (continue reading...)

A First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID, Influenzas and More

SHELTON, CT / ACCESSWIRE / June 4, 2024 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), a clinical-stage global leader in broad-spectrum antiviral nanomedicines, reports on the highly desirable blood concentration profile of its lead clinical stage broad-spectrum antiviral agent NV-387 upon intravenous (I.V.)... (continue reading...)